ストックスクリーナーアプリを入手
17.16
0.41%
0.07
アフターアワーズ：
17.16
前日終値:
$17.09
開ける：
$17.05
24時間の取引高:
741.31K
Relative Volume:
0.85
時価総額：
$1.81B
収益：
-
当期純損益:
$-150.70M
株価収益率:
-11.07
EPS:
-1.55
ネットキャッシュフロー:
$-125.67M
1週間 パフォーマンス:
-6.13%
1か月 パフォーマンス:
+13.34%
6か月 パフォーマンス:
+18.18%
1年 パフォーマンス:
-51.57%
1日の値動き範囲:
$16.70
$17.65
1週間の範囲:
$16.70
$18.61
52週間の値動き範囲:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
EWTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
17.16 | 1.80B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-25 | 開始されました | Goldman | Neutral |
| 2025-07-30 | 開始されました | Raymond James | Strong Buy |
| 2025-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2025-04-30 | 開始されました | Guggenheim | Buy |
| 2025-04-02 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2025-01-22 | 開始されました | Stifel | Hold |
| 2024-11-22 | 開始されました | Evercore ISI | Outperform |
| 2024-03-07 | 開始されました | Piper Sandler | Overweight |
| 2023-05-01 | 開始されました | Truist | Buy |
| 2022-08-25 | ダウングレード | Goldman | Neutral → Sell |
| 2022-04-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-01-28 | 開始されました | Goldman | Neutral |
すべてを表示
Edgewise Therapeutics Inc (EWTX) 最新ニュース
Does Edgewise Therapeutics Inc. show high probability of reboundWeekly Volume Report & Target Return Focused Picks - newser.com
What valuation multiples suggest for Edgewise Therapeutics Inc. stockBuy Signal & Technical Pattern Based Signals - newser.com
RBC Adjusts Price Target on Edgewise Therapeutics to $50 From $49, Maintains Outperform Rating - MarketScreener
How to track smart money flows in Edgewise Therapeutics Inc.Quarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
Real time breakdown of Edgewise Therapeutics Inc. stock performanceOptions Play & High Accuracy Swing Trade Signals - newser.com
Wedbush Lowers Price Target on Edgewise Therapeutics to $32 From $35, Keeps Outperform Rating - MarketScreener
Edgewise Therapeutics (NASDAQ: EWTX) sets Nov–Dec investor fireside chats; webcasts - Stock Titan
Edgewise Therapeutics Inc. stock prediction for this weekJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com
Risk vs reward if holding onto Edgewise Therapeutics Inc.July 2025 Pullbacks & Low Drawdown Investment Strategies - newser.com
Edgewise Therapeutics Reports Q3 2025 Financial Results - TipRanks
Decoding Edgewise Therapeutics Inc (EWTX): A Strategic SWOT Insi - GuruFocus
Edgewise Therapeutics' Q3 Net Loss Widens, Beats Estimate; Shares Rise - MarketScreener
Edgewise Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings Flash (EWTX) Edgewise Therapeutics Posts Q3 Net Loss $0.39 a Share, vs. FactSet Est of $0.42 Loss - MarketScreener
Edgewise Therapeutics Q3 net loss widens as R&D costs rise - MarketScreener
Edgewise Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire
Chart overlay techniques for tracking Edgewise Therapeutics Inc.2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
Is Edgewise Therapeutics Inc. stock supported by innovation pipelineJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com
Multi asset correlation models including Edgewise Therapeutics Inc.Volume Spike & Verified Chart Pattern Signals - newser.com
Strategies to average down on Edgewise Therapeutics Inc.2025 Dividend Review & Verified Entry Point Detection - newser.com
Real time alert setup for Edgewise Therapeutics Inc. performancePortfolio Return Report & Smart Money Movement Alerts - newser.com
What hedge fund activity signals for Edgewise Therapeutics Inc. stock2025 Market Sentiment & Growth Focused Investment Plans - newser.com
Is Edgewise Therapeutics Inc. trending in predictive chart modelsPortfolio Return Report & Free Technical Confirmation Trade Alerts - newser.com
Risk adjusted return profile for Edgewise Therapeutics Inc. analyzedJuly 2025 Review & Capital Efficiency Focused Strategies - newser.com
How Edgewise Therapeutics Inc. stock reacts to oil pricesPortfolio Update Report & Long-Term Capital Growth Ideas - fcp.pa.gov.br
Detecting price anomalies in Edgewise Therapeutics Inc. with AIEarnings Overview Report & Growth Focused Entry Point Reports - newser.com
Published on: 2025-11-05 01:23:25 - newser.com
Exit strategy if you’re trapped in Edgewise Therapeutics Inc.Options Play & Daily Growth Stock Tips - newser.com
Published on: 2025-11-04 23:53:31 - newser.com
Analyzing Edgewise Therapeutics Inc. with risk reward ratio charts2025 Momentum Check & Safe Capital Growth Tips - newser.com
How Edgewise Therapeutics Inc. stock performs in stagflationJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Lelezard
Truist Securities reiterates Buy rating on Edgewise Therapeutics stock By Investing.com - Investing.com Canada
Edgewise Therapeutics prepares for pivotal research in cardiovascular medicine - Traders Union
Can Edgewise Therapeutics Inc. stock beat analyst upgradesJuly 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com
What recovery options are there for Edgewise Therapeutics Inc.2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Edgewise Therapeutics Inc (EWTX) 財務データ
収益
当期純利益
現金流量
EPS
Edgewise Therapeutics Inc (EWTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Russell Alan J | Chief Scientific Officer |
Aug 26 '25 |
Sale |
14.60 |
100,000 |
1,459,760 |
23,400 |
5.44%
0.70%
大文字化:
|
ボリューム (24 時間):